European Pharmaceutical Review

APRIL 12, 2024

There has been a “notable” rise in licensing agreements for innovator drugs incorporating clustered regularly interspaced short palindromic repeats (CRISPR)-based technology for gene therapies over the past five years, according to data and analytics firm GlobalData. These agreements have amassed a total deal value of $21 billion.

FDA 83

FDA 83

Pharmaceutical Technology

DECEMBER 19, 2023

Pharmaceutical Technology outlines some of the biggest US Food and Drug Administration (FDA) drug approvals announced in 2023 that are set to make an impact in the coming years.

FDA 105

FDA 105

STAT

JANUARY 26, 2024

Share the news with us, and we’ll share it with others.   Send us your changes, and we’ll find a home for them.  Don’t This time around, we note that  Eleven Therapeutics hired Paloma Giangrande as chief technology officer. Hired someone new and exciting? Promoted a rising star?

90

90

European Pharmaceutical Review

APRIL 17, 2024

Another driving factor for its growth is more efficient sterility testing due to technological advancements, the report stated. US) Merck KGaA (Germany) Rapid Micro Biosystems, Inc. (US) Techniques such as membrane filtration sterility testing are drivers for CAGR. For example, this is due to demand for liquid formulations.

Dosage 85

Dosage Compounding 85

STAT

FEBRUARY 8, 2024

What can machines teach us about medicine? First, STAT’s Casey Ross joins us to explain his reporting on how researchers and pharmaceutical firms are using the technology to find new drug targets, design therapies, and improve clinical trials. And what’s a digital twin? It’s our all-AI episode.

102

102

PharmaShots

JANUARY 27, 2023

Shots:· Under the terms of the agreement, both companies will jointly distribute Vscan Air Handheld Ultrasound across the US for ultrasound applications in veterinary care to diagnose a range of conditions in dogs, cats, horses, cows, pigs, goats & exotic animals· Additionally, Sound imaging will be the exclusive distributor for Vscan (..)

40

40

European Pharmaceutical Review

APRIL 4, 2024

US radiopharmacy network RLS Radiopharmacies is expanding its radiopharmaceutical contract development and manufacturing (rCDMO) capabilities by establishing a partnership with global isotope technology company Eckert & Ziegler.

81

81

STAT

FEBRUARY 29, 2024

“We have a very early think tank on: what would it take us, from a technology point of view and from an ecosystem point of view, to make long-lasting GLP-1 molecules?” ” Marcus Schindler, Novo’s chief scientific officer, said in an interview with STAT Wednesday.

Vaccines 132

Vaccines 132

PharmaShots

FEBRUARY 3, 2023

Shots: Abbott’s FlexAbility sensor enabled ablation catheter received the US FDA approval for a new indication.

FDA 40

FDA 40

STAT

NOVEMBER 1, 2023

General Catalyst’s plan to take over a hospital in the coming months could be the first of many such deals, driven by financially strained hospitals looking for saviors, and venture capitalists convinced that they have the technology solutions for fixing the health care sector’s vexing problems.

Hospitals 119

Hospitals 119

The Guardian - Pharmaceutical Industry

JANUARY 16, 2024

The company’s Harwell site is Britain’s first centre dedicated to the production of messenger RNA (mRNA) vaccines against new Covid variants and other illnesses, and part of the UK’s “100 days mission” initiative – the ambition for governments to be able to respond to future pandemics within 100 days of a threat being identified.

Vaccines 122

Vaccines 122

European Pharmaceutical Review

FEBRUARY 15, 2024

Additionally, various technologies and expertise have been added to support drug substances, drug products, raw materials, and primary container closure release and stability studies. The new isolator suite will complement the existing sterility assurance capabilities at the lab.

90

90

pharmaphorum

MARCH 13, 2024

Join us at the Injectable Drug Delivery Conference and Exhibition to explore the latest advancements and innovations in the field of injectable drug delivery technologies. Learn from industry experts and network with key players in the industry.

52

52

STAT

NOVEMBER 17, 2023

“We partnered closely with leading experts in our clinical community who could help us in our journey to get this technology to the people who need it most.” “Medtronic has always believed in the potential of this therapy,” Jason Weidman, renal denervation head at Medtronic, said in a statement.

FDA 121

FDA 121

European Pharmaceutical Review

MARCH 14, 2023

“Together, Pfizer and Seagen seek to accelerate the next generation of cancer breakthroughs and bring new solutions to patients by combining Seagen’s antibody -drug conjugate (ADC) technology… with Pfizer’s capabilities and expertise,” shared Dr Albert Bourla, Pfizer Chairman and Chief Executive Officer. billion of revenue in 2023.

FDA 108

FDA 108

STAT

SEPTEMBER 13, 2022

Both of us have spent much of our lives in wheelchairs. Ours are equipped with power seat elevation and standing technologies individually configured to meet our needs. At the push of a button, our wheelchairs can elevate us to eye level with a nondisabled person or position us in a “standing” posture.

112

112

STAT

DECEMBER 14, 2023

Reese is becoming the company’s chief technology officer. “For more than 40 years, Amgen’s focus on innovation has enabled us to deliver life-changing medicines to patients suffering from serious diseases around the world,” Robert Bradway, Amgen’s CEO, said in a statement.

115

115

Pharmaceutical Technology

AUGUST 1, 2022

Moderna has entered a new supply contract with the US Government to deliver 66 million doses of its Covid-19 vaccine booster candidate, mRNA-1273.222. On the US exercising options, the doses could total 300 million. 5, the most prevalent variants of concern in the US today. “We 4/5 strain messenger RNA (mRNA).

Vaccines 115

Vaccines FDA 115

Pharmaceutical Technology

AUGUST 28, 2022

Moderna has f iled patent infringement lawsuits in the US District Court for the District of Massachusetts and the Regional Court of Düsseldorf in Germany against Pfizer and BioNTech over messenger ribonucleic acid (mRNA) technology. This technology was vital for developing Spikevax, an mRNA Covid-19 vaccine of Moderna.

Vaccines 98

Vaccines 98

Pharmaceutical Technology

MARCH 8, 2023

The US Food and Drug Administration (FDA) has granted approval for Shorla Oncology’s Nelarabine Injection, an oncology drug, to treat T-cell leukaemia, an aggressive blood and bone marrow cancer that progresses quickly. The regulatory approval marks the company’s first product to receive approval in the US market.

FDA 98

FDA Patient Care 98

European Pharmaceutical Review

FEBRUARY 27, 2024

Amgen has opened a new biomanufacturing plant in Central Ohio, US. The new facility, known as Amgen Ohio, “was designed with the latest innovation and technology to deliver safe, reliable medicines for ‘every patient, every time,'” stated Robert Bradway, Chairman and Chief Executive Officer at Amgen.

Pharmaceutical Companies 100

Pharmaceutical Companies Pharmaceutical Companies FDA 100

Pharma Mirror

APRIL 21, 2024

The healthcare landscape is rapidly transforming, fueled by the convergence of technology and medicine. In 2021, the industry was valued at an impressive US$ 91.71 As we delve into the IoT in Healthcare Market Outlook for 2031, the data paints a vivid picture of an industry poised for unprecedented growth and innovation.

Patient Care 52

Patient Care 52

STAT

OCTOBER 26, 2023

Our colleague Andrew Joseph joins us to explain the decades-old cancer-treating technology that had its star turn at this week’s big oncology conference in Europe. And why are venture capitalists so optimistic? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast.

92

92

Pharmafile

APRIL 4, 2023

Phlo Technologies UK digital pharmacy leaders, have today announced their acquisition of the UK arm of US-based healthcare unicorn Truepill. read more

Medication Dispensing 52

Medication Dispensing 52

European Pharmaceutical Review

MARCH 20, 2024

For example, Germany occupied a market share of 21 percent as it is considered the most research-intensive economy after the US and China. In contrast, the report shared that the US is the biggest revenue contributor in the global market. Based on the research, the US LIMS market is predicted to value $1 billion by 2028.

94

94

Pharmafile

MARCH 30, 2023

Hovione, a CDMO, and Laxxon Medical, a pharma-technology company, have signed a strategic partnership deal to bring 3D printing technologies to the pharmaceutical industry. The agreement will see Laxxon Medical placing 3D screen printing technology at Hovione’s cGMP production sites in Portugal initially, then the US.

Communication 58

Communication 58

STAT

SEPTEMBER 5, 2023

We often overlook jobs in another key climate technology sector: biotechnology. This is because biotech lets us ferment all kinds of physical goods, in the same way we ferment beer and wine, instead of extracting them from petroleum, plants, or animals. Biotech is often perceived to be synonymous with pharma.

Vaccines 129

Vaccines 129

STAT

FEBRUARY 1, 2023

Since then, it has been called world-changing , a tipping point for artificial intelligence, and the beginning of a new technological revolution. Although the potential usage of AI such as ChatGPT for medical applications excites us, inaccuracies, confabulation, and bias make us hesitant to endorse its use outside of certain situations.

109

109

Outsourcing Pharma

AUGUST 3, 2021

The success of mRNA vaccine technology could be one of the new opportunities for US pharmaceutical manufacturing looking forward, with pandemic investments helping turbocharge the sector.

Vaccines 111

Vaccines 111

European Pharmaceutical Review

MARCH 22, 2023

Hovione, a contract development and manufacturing organisation (CDMO) and Laxxon Medical, a pharma-tech company will collaborate to advance 3D screen printing technologies for the pharmaceutical industry. The post Collaboration to produce 3D screen printed pharmaceuticals appeared first on European Pharmaceutical Review.

Dosage 91

Dosage 91

The FDA Law Blog

APRIL 8, 2024

The role of technology on quality was another feature. The report highlighted CDER’s Framework for Regulatory Advanced Manufacturing Evaluation Initiative and OPQ’s own Emerging Technology Program. Like many of us, OPQ seems intent on trying to keep up with how technology can/will impact pharmaceutical quality.

FDA 59

FDA Immunization 59

Pharmaceutical Technology

SEPTEMBER 6, 2022

The US Food and Drug Administration (FDA) has awarded Orphan Drug Designation (ODD) to Avacta Group’s lead pre|CISION drug candidate, AVA6000, to treat soft tissue sarcoma. Updated using the pre|CISION technology, AVA6000 is a kind of generic chemotherapy doxorubicin.

FDA 98

FDA Chemotherapy 98

Pharmaceutical Technology

AUGUST 12, 2022

In June this year, it was announced that the US Food and Drug Administration (FDA) had granted UK-based OxfordVR a breakthrough device designation for its gameChangeVR treatment to deliver immersive cognitive behaviour therapy (CBT) to people suffering from schizophrenia and other mental illnesses. million people in the UK and 2.7

FDA 141

FDA 141

Pharmaceutical Technology

MARCH 1, 2023

Venture financing for early-stage innovator drugs for biotech companies based in the Asia-Pacific (APAC) region between 2018 to 2022 received three times less funding, at $23bn, than their US counterparts, at $72bn, according to GlobalData’s Pharma Intelligence Centre Deals Database. Hangzhou DAC Biotech, based in China, raised $155.4m

Pharmaceutical Companies 72

Pharmaceutical Companies Pharmaceutical Companies 72

Hospital Pharmacy Europe

MAY 18, 2023

Based on discussions at an event led by the FIP Technology Advisory Group in February, the report considers the progress achieved, maintained and accelerated in the digitalisation of both hospital and community pharmacy since the Covid-19 pandemic.

Community Pharmacies 98

Community Pharmacies Hospitals Patient Care Process Improvement 98

Pharmaceutical Technology

AUGUST 1, 2022

GreenLight Biosciences has entered a partnership with the US National Institutes of Health (NIH) for the development of Covid-19 vaccines, which offer broader protection against new variants and with durable effects. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Vaccines 98

Vaccines Immunization 98

Pharmaceutical Technology

OCTOBER 7, 2022

Provention Bio and Sanofi US have signed a co-promotion agreement to launch the former’s lead investigational drug candidate, teplizumab for the delay in the onset of clinical type 1 diabetes (T1D). The US Food and Drug Administration (FDA) is presently reviewing teplizumab for the delay of clinical T1D in people who are at risk.

FDA 119

FDA 119